Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 16.00.
Forward PE Ratio (16.00) = Close Price ($24.74) / Consensus Forward EPS ($1.55)
FORWARD PE RATIO
16.00
SECTOR MEDIAN · HEALTHCARE
20.07
median of 69 covered companies
CURRENT VS SECTOR MEDIAN
-20.28%
vs the sector median at left
Doximity, Inc.
Market Cap
$4.63B
Forward PE Ratio
16.00
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Doximity, Inc. (DOCS) | $4.63B | 16.00 |
| TransMedics Group, Inc. (TMDX)vs › | $3.19B | 62.56 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.65B | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.19B | 7.17 |
| Oscar Health, Inc. (OSCR)vs › | $8.10B | 17.94 |
| Teladoc Health, Inc. (TDOC)vs › | $1.15B | N/A |
| NRC Health (NRC)vs › | $495.81M | 25.02 |
| Shoulder Innovations, Inc. (SI)vs › | $465.16M | N/A |
| Insulet Corp. (PODD)vs › | $9.93B | 22.00 |
| Henry Schein, Inc. (HSIC)vs › | $10.30B | 16.79 |
Trailing P/E
29.1
reported TTM EPS
Forward P/E
16.0
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $1.55 implies +82.4% EPS growth vs the reported trailing $0.85.
At today's $24.74 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-03-31 | $1.35 | $1.24 – $1.50 | 11 | 18.4x |
| 2028-03-31 | $1.55 | $1.40 – $1.77 | 10 | 15.9x |
| 2029-03-31 | $1.83 | $1.47 – $2.10 | 3 | 13.5x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
